Rivaara Immune Private Limited

Develops immunotherapy treatments for cancer and makes them accessible to patients.

2019 | Mumbai, Maharashtra (India) | Active
Last Updated:

Rivaara Immune Profile

Key Indicators

  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth -100.00%
  • Profit Growth -31.02%
  • Ebitda -30.99%
  • Net Worth -14.99%
  • Total Assets 39.36%

About Rivaara Immune

Rivaara Immune Private Limited (RIPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 August 2019 (Five years and eight months 24 days old ). Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Healthcare Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Mayank Shah and Siddharth Daftary serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U85200MH2019PTC329805

  • Company No.

    329805

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    27 Aug 2019

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Healthcare
Company report

Rivaara Immune Private Limited

Explore comprehensive data for Rivaara Immune Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Rivaara Immune?

Board Members (2)

NameDesignationAppointment DateStatus
Mayank Shah Country flag representing In Director 05-Jan-2024Current
Siddharth Daftary Country flag representing In Director 27-Aug-2019Current

Financial Performance of Rivaara Immune.

Rivaara Immune Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 31.02% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.99%.

Rivaara Immune revenue growth over time
Rivaara Immune profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-100.00%
Revenue from Operations
Total Assets
39.36%
Profit or Loss
-31.02%
Net Worth
-14.99%
EBITDA
-30.99%

What is the Ownership and Shareholding Structure of Rivaara Immune?

Unlock access to Rivaara Immune's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Rivaara Immune?

Unlock and access historical data on people associated with Rivaara Immune, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Rivaara Immune Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rivaara Immune, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rivaara Immune's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Rivaara Immune

Recent activity within the organization

  • Annual General Meeting

    Rivaara Immune Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Rivaara Immune Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

  • Director Appointment

    Mayank Jayantilal Shah was appointed as a Director was appointed as a Director on 05 Jan 2024 & has been associated with this company since 1 year 4 months .

  • Director Appointment

    Siddharth Bharat Daftary was appointed as a Director was appointed as a Director on 27 Aug 2019 & has been associated with this company since 5 years 8 months .

  • Company Incorporation

    Rivaara Immune Private Limited was registered on 27 Aug 2019 with Roc Mumbai & aged 5 years 8 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Rivaara Immune Private Limited?

    Rivaara Immune Private Limited was incorporated on 27 Aug 2019.

  • What is authorized share capital and paid-up capital of Rivaara Immune Private Limited?

    The authorized share capital of Rivaara Immune Private Limited is ₹ 10.00 Cr and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Rivaara Immune Private Limited?

    Currently 2 directors are associated with Rivaara Immune Private Limited.

    • Mayank Jayantilal Shah
    • Siddharth Bharat Daftary

  • What is the registered address of Rivaara Immune Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Rivaara Immune Private Limited is 17Th Floor Hoechst House, Nariman Point India, Mumbai, Maharashtra, 400021.

  • What is the corporate identification number (CIN) and company number of Rivaara Immune Private Limited?

    The corporate identification number (CIN) of Rivaara Immune Private Limited is U85200MH2019PTC329805 and the company number is 329805 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Rivaara Immune Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Rivaara Immune Private Limited has fallen by -100.00%.

  • What change has been observed in the net worth of Rivaara Immune Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Rivaara Immune Private Limited has experienced an downturn of -14.99%.

  • When was the last Balance Sheet of Rivaara Immune Private Limited filed with the ROC?

    The most recent Balance Sheet for Rivaara Immune Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Oncology Clinics & Cancer Treatment